AWM
GNMK

AE Wealth Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

AE Wealth Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-46,850
Closed -$665K – 1466
2020
Q3 		$665K Buy
+46,850
New +$716K 0.01% 759

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AE Wealth Management's GNMK Position: Q4 2020 in Review

AE Wealth Management sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 46,850 shares — an estimated $665K sold.

AE Wealth Management first reported a position in GNMK in Q3 2020 and held it in 1 quarter. The position peaked at $665K in Q3 2020. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

  • AE Wealth Management reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
  • AE Wealth Management sold 46,850 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $665K.
  • AE Wealth Management first reported a position in GenMark Diagnostics, Inc in Q3 2020 and held it in 1 quarter.
  • AE Wealth Management's GenMark Diagnostics, Inc position peaked at $665K in Q3 2020.
  • 151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on AE Wealth Management's 13F filing for Q4 2020, filed 1 Feb 2021.